Simpler Grants.gov #HT942526LRPTVA

Defense Health Agency solicits proposals for Lupus Transformative Vision Award research grant

The Defense Health Agency is soliciting applications for the FY26 Lupus Research Program Transformative Vision Award (TVA), targeting interventional research to improve quality of life for individuals with lupus. - Government Buyer: - Defense Health Agency (DHA) - Defense Health Agency Research and Development (DHA R&D) - Defense Health Agency Contracting Activity (DHACA) - OEMs and Vendors: - No specific OEMs or commercial vendors are mentioned; this is a research grant opportunity. - Products/Services Requested: - Interventional lupus research services - Focus on clinical trials and interventions at the individual or health care system level - Excludes animal studies - Must address at least one Transformative Vision Award focus area - Requires preliminary data - Must include at least one lupus consumer advocate on the research team - Supports up to three Principal Investigators per project - Service line item: FY26 Lupus Research Program Transformative Vision Award (TVA), part number HT942526LRPTVA, quantity 1 - Unique or Notable Requirements: - Multidisciplinary collaborations encouraged, including Department of War and Veterans Affairs entities - Unrestricted eligibility; no cost sharing or matching required - Compliance with federal registration requirements (SAM.gov, eBRAP.org, Grants.gov) - Maximum funding cap of $2,000,000 for one award - Maximum period of performance is four years - Place of Performance: - Service Members, Veterans, their Families, and the general public (federal facility context) - US Army Medical Research Acquisition Activity (USAMRAA) (contracting office)

Description

This funding mechanism supports interventional research at the individual and/or health care system level aimed at near-term impact on the health-related quality of life of individuals living with lupus. Research must address at least one of the fiscal year 2026 Lupus Research Program Transformative Vision Award focus areas. The mechanism allows for clinical trials but excludes animal studies. Applications must include preliminary data and at least one lupus consumer advocate as a member of the research team. Up to three Principal Investigators are allowed, with specific application submission requirements for initiating and partnering PIs.

View original listing